Novel nucleotide triphosphates as potent P2Y2 agonists
- 15 January 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (2) , 562-565
- https://doi.org/10.1016/j.bmcl.2006.09.017
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Structure–activity relationships of dinucleotides: Potent and selective agonists of P2Y receptorsPurinergic Signalling, 2005
- Inhaled P2Y2 receptor agonists as a treatment for patients with Cystic Fibrosis lung diseaseAdvanced Drug Delivery Reviews, 2002
- Synthesis of novel substituted isoquinolonesTetrahedron, 2002
- Tear Lipocalin: Structure, Function and Molecular Mechanisms of ActionPublished by Springer Nature ,2002
- Pharmacology of INS37217 [P1-(Uridine 5′)-P4- (2′-deoxycytidine 5′)tetraphosphate, Tetrasodium Salt], a Next-Generation P2Y2 Receptor Agonist for the Treatment of Cystic FibrosisThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Synthesis and P2Y receptor activity of a series of uridine dinucleoside 5′-polyphosphatesPublished by Elsevier ,2001
- Purinergic and pyrimidinergic receptors as potential drug targetsBiochemical Pharmacology, 2000
- P2Y2 receptors agonists: Structure, activity and therapeutic utilityDrugs of the Future, 1999